Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion

Obesity Surgery

Volumn 17, Issue 3, 2007, Pages 348-354

  Moreiro, J ^a,b   Ruiz, O ^a   Perez, G ^a   Salinas, R ^a   Urgeles, J R ^a   Riesco, M ^a   Garcia Sanz M ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b Endocrinology and Nutrition   (Spain)

Author keywords

Bariatric surgery; Biliopancreatic diversion; Bone markers; Intestinal malabsorption; Morbid obesity; Parathyroid hormone; Secondary hyperparathyroidism; Short intestine syndrome; Vitamin D

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; CREATININE; DEOXYPYRIDINOLINE; PARATHYROID HORMONE;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; BONE ATROPHY; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; FEMALE; HIGH RISK PATIENT; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM; SUPPLEMENTATION; SURGICAL RISK; TREATMENT OUTCOME; URINE LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; BILIOPANCREATIC DIVERSION; CALCIFEDIOL; CALCIUM; COLLAGEN; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PARATHYROID HORMONE;

EID: 34247488669     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9063-9     Document Type: Article

References (40)

1. Otrowska Z, Zwirska-Korczala K, Buntner B et al. Assessment of bone metabolism in obese women. Endocrine Regulations 1998; 32: 177-81.
2. Hey H, Stokholm KH, Lund B et al. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes 1982; 6: 473-9.
3. Wortsman J, Matsuoka LY, Chen TC et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2003; 72: 690-3.
4. Hamoui N, Anthone G, Crookes PF. Calcium metabolism in the morbidly obese. Obes Surg 2004; 14: 9-12.
5. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone level is associated with body mass index. Eur J Endocrinol 2005; 151: 167-72.
6. Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg 2004; 14: 1157-64.
7. Slater GH, Ren CJ, Siegel N et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004; 8: 48-55.
8. Goldner WS, O'Dorisio TM, Dillon JS et al. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg 2002; 12: 685-92.
9. Hamoui N, Kim K, Anthone G et al. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 2003; 138: 891-7.
10. De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci 2005; 329: 57-61.
11. Fujioka K. Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care 2005; 28: 481-4.
12. Chapin BL, LeMar HJJ, Knodel DH et al. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg 1996; 131: 1048-52.
13. Sahota O, Masud T, San P et al. Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis. Clin Endocrinol 1999; 51: 217-21.
14. Bloomberg RD, Fleishman A, Nalle JE et al. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 2005; 15: 145-54.
15. Marceau P, Biron S, Lebel S et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg 2002; 6: 690-8.
16. Scopinaro N. Laparoscopic BPD (commentary). Obes Surg 2000; 10: 524.
17. Scopinaro N, Marinari GM, Camerini G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg 2002; 12: 241-4.
18. Christenson RH. Biochemical markers of bone metabolism: an overview. Clin Biochem 1997; 30: 573-93.
19. Price C, Thompson P. The role of biochemistry test in the screening and monitoring of osteoporosis. Ann Clin Biochem 1995; 32: 244-60.
20. Demers L. Clinical usefulness of markers of bone degradation and formation. Scand J Clin Lab Invest 1997; 57: 12-20.
21. Panteghini M, Pagani F. Biological variation in urinary excretion of pyridinium crosslinks: recommendations for the optimum specimen. Ann Clin Biochem 1996; 33: 36-42.
22. Gundarmann KD. Bioluminescence and Chemiluminescence - Basic Chemistry and Analytical Applications. New York: Academic Press, 1981: 17-9.
23. Wood WG. Luminescence immunoassays. J Clin Chem Clin Biochem 1984; 22: 905-18.
24. Bell NH, Epstein S, Greene A et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370-3.
25. Jorde R, Bonaa KH, Sundsfjord J et al. Population based study on serum ionised calcium, serum parathyroid hormone, and blood pressure. The Tromso study. Eur J Endocrinol 1999; 141: 350-7.
26. Cundy T, Evans MC, Kay R et al. Effects of vertical banded gastroplasty on bone and mineral metabolism in obese patients. Br J Surg 1996; 83: 1468-72.
27. Pugnale N, Giusti V, Suter M et al. Bone metabolism and risk of secondary hyperparathyroidism months after gastric banding in obese pre-menopausal women. Int J Obes 2003; 27: 110-6.
28. Shaker JL, Norton AJ, Woods MF et al. Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporos Int 1991; 1: 177-81.
29. Diniz M de F, Diniz MT, Sanches SR et al. Elevated serum parathormone after Roux-en-Y gastric bypass. Obes Surg 2004; 14: 1222-6.
30. Newbury L, Dolan K, Hatifotis M et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 2003; 13: 893-5.
31. Goode LR, Brolin RE, Chowdhury HA et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Surg 2004; 12: 40-7.
32. Coates PS, Fernstrom JD, Fernstrom MH et al. Gastric bypass surgery for morbid obesity leads to an increase of bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004; 89: 1059-60.
33. Guney E, Kisakol G, Ozgen G et al.. Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg 2003; 13: 383-8.
34. Bowen J, Noakes M, Clifton PM. A high dairy protein, high-calcium diet minimizes bone turnover in overweight adults during weight loss. J Nutr 2004; 134: 568-73.
35. Worsfold M, Powell DE, Jones T et al. Assessment of urinary bone markers for monitoring treatment of osteoporosis. Clin Chem 2004; 50: 2263-70.
36. Von Mach MA, Stoeckli R, Kraenzlin M et al. Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism 2004; 53: 918-21.
37. Shapses SA, Von Thun NL, Heymsfield SB et al. Bone turnover and density in obese pre-menopausal women during moderate weight loss and calcium supplementation. J Bone Miner Res 2001; 16: 1329-36.
38. Okabe R, Inaba M, Nakatsuka K et al. Significance of serum CrossLap as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline. J Bone Miner Metab 2004; 22: 127-31.
39. Huber F, Traber L, Roth H et al. Markers of bone resorption-measurement in serum, plasma or urine. Clin Lab 2003; 49 (5-6): 203-7.
40. Peichl P, Griesmacherb A, Marteau R et al. Serum Crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Clin Biochem 2001; 34: 131-4.